Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Moderately high prolactin levels do not cause hair loss in women.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The critique suggests that Wilton's work unintentionally supports the very stereotypes it aims to question and calls for a broader, more inclusive approach to understanding gender.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Acne is a chronic skin condition not caused by poor hygiene or diet, and it requires long-term treatment and patient education.

Androgens contribute to common male hair loss; more research needed for hair growth medication.